Johnson & Johnson MedTech announced positive three-month results from a study evaluating its investigational Omnypulse platform.

The FDA’s head during the Biden administration, Dr. Robert Califf, repeatedly said that the agency’s current regulatory model, in which approved devices are generally not scrutinized again, doesn’t ...

HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading Siemens Healthineers AG (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting Align Technology (NASDAQ:ALGN), ...

The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of ...

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) in Q1 CY2025, with sales up 2.4% year on year to $21.89 billion ...

Michael Hoey admits he’s terrible at names. He used to call his kids “One, Two and Three.” When naming his startup seeking to ...

Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board ...

For the first quarter of this year, J&J’s total sales of $21.9 billion were up 4.2% over the start of 2024, when accounting ...

Umvuzo Health celebrates 21 years with AI-powered wearables, DNA testing, and gut microbiome analytics—offering a bold new ...

Consolidation in the spine medtech space has been a constant in recent years from large mergers to smaller company acquisitions. For spine surgeons the transforming landscape presents opportunities ...

Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of DRG ...